Spots Global Cancer Trial Database for Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers
Official Title: Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers
Study ID: NCT00421213
Interventions
Study Description
Brief Summary: The study of safety of a new organic arsenic compound in the treatment of hematological malignancies.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Miami, Florida, United States
, Chicago, Illinois, United States
, Bethesda, Maryland, United States
, Fargo, North Dakota, United States
, Sioux Falls, South Dakota, United States
, Morgantown, West Virginia, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
